BVCF (Bioveda China Fund)

cb Email

Status

ACTIVE

Global HQ

Beijing, China

Countries of investment

China and the USA

Investment stages

Seed
Series A
Series B

Industries

Health Tech
Biotechnology
AI
Fintech

About
BVCF (BioVeda China Fund) has established itself as a leader in fostering innovative life sciences companies in China since its inception in 2005. Committed to enhancing global health and wealth, BVCF specializes in identifying and nurturing high-potential ventures that contribute to advancements in healthcare. By attracting a diverse range of global institutional investors, the fund strategically positions itself to drive the growth of transformative solutions within the life sciences sector. Through its dedicated approach and deep industry expertise, BVCF is shaping the future of health innovation on a global scale.

Min check size: $100K
Max check size: $30M
Fund size: Unlock
NPS: Unlock

Investment Thesis

BVCF focuses on creating and developing innovative global Chinese life sciences companies. The fund aims to build transformative healthcare companies by leveraging its deep industry knowledge and strategic insights.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Possessing extensive experience in private equity and venture capital, the fund manager has successfully led over thirty investments across technology and healthcare sectors in North America and Europe. Emphasizing a data-driven approach, they have orchestrated notable exits that highlight their strategic insight and ability to identify market trends. Their investment strategies are characterized by a focus on early-stage companies, leveraging operational expertise to drive growth and value creation. The manager’s thematic investing style ensures alignment with evolving industry dynamics and robust return potential.